Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OmegaREMODEL: High Dose Fish Oil in Recent MI
NCT00729430Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2008
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in myocardial infarction (MI), sponsored by Brigham and Women's Hospital. Started Aug 2008; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00729430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729430.